Cyclin-Dependent Kinase CRK9, Required for Spliced Leader trans Splicing of Pre-mRNA in Trypanosomes, Functions in a Complex with a New L-Type Cyclin and a Kinetoplastid-Specific Protein

Autor: Sung Hee Park, Justin K. Kirkham, Arthur Günzl, Nitika Badjatia, Daniela Luz Ambrósio
Přispěvatelé: University of Connecticut Health Center, The Pennsylvania State University, Universidade de São Paulo (USP)
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Polyadenylation
RNA splicing
Trans-splicing
RNA polymerase II
Protozoology
Biochemistry
Trans-Splicing
Mice
Gene expression
RNA Precursors
Cell Cycle and Cell Division
Post-Translational Modification
Phosphorylation
lcsh:QH301-705.5
Phylogeny
Protozoans
Mice
Inbred BALB C

biology
Cyclin-Dependent Kinases
3. Good health
Nucleic acids
Cell Processes
Female
RNA Polymerase II
Sequence Analysis
Research Article
lcsh:Immunologic diseases. Allergy
RNA
Spliced Leader

Trypanosoma
Immunology
Trypanosoma brucei brucei
Research and Analysis Methods
Microbiology
03 medical and health sciences
Cyclin-dependent kinase
Sequence Motif Analysis
Virology
Cyclins
Proliferating Cell Nuclear Antigen
Genetics
Animals
Molecular Biology Techniques
Sequencing Techniques
Gene
Molecular Biology
030102 biochemistry & molecular biology
Organisms
RNA
Biology and Life Sciences
Proteins
Kinetoplastids
Cell Biology
Molecular biology
Parasitic Protozoans
030104 developmental biology
lcsh:Biology (General)
RNA processing
biology.protein
Parasitology
lcsh:RC581-607
Sequence Alignment
Trypanosoma Brucei Gambiense
Zdroj: Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
PLoS Pathogens
PLoS Pathogens, Vol 12, Iss 3, p e1005498 (2016)
Popis: In eukaryotes, cyclin-dependent kinases (CDKs) control the cell cycle and critical steps in gene expression. The lethal parasite Trypanosoma brucei, member of the phylogenetic order Kinetoplastida, possesses eleven CDKs which, due to high sequence divergence, were generically termed CDC2-related kinases (CRKs). While several CRKs have been implied in the cell cycle, CRK9 was the first trypanosome CDK shown to control the unusual mode of gene expression found in kinetoplastids. In these organisms, protein-coding genes are arranged in tandem arrays which are transcribed polycistronically. Individual mRNAs are processed from precursor RNA by spliced leader (SL) trans splicing and polyadenylation. CRK9 ablation was lethal in cultured trypanosomes, causing a block of trans splicing before the first transesterification step. Additionally, CRK9 silencing led to dephosphorylation of RNA polymerase II and to hypomethylation of the SL cap structure. Here, we tandem affinity-purified CRK9 and, among potential CRK9 substrates and modifying enzymes, discovered an unusual tripartite complex comprising CRK9, a new L-type cyclin (CYC12) and a protein, termed CRK9-associated protein (CRK9AP), that is only conserved among kinetoplastids. Silencing of either CYC12 or CRK9AP reproduced the effects of depleting CRK9, identifying these proteins as functional partners of CRK9 in vivo. While mammalian cyclin L binds to CDK11, the CRK9 complex deviates substantially from that of CDK11, requiring CRK9AP for efficient CRK9 complex formation and autophosphorylation in vitro. Interference with this unusual CDK rescued mice from lethal trypanosome infections, validating CRK9 as a potential chemotherapeutic target.
Author Summary Kinetoplastids are vector-borne, unicellular parasites that cause devastating human diseases in the tropics and subtropics of the world. Interestingly, kinetoplastids express protein-coding genes differently than other eukaryotes by producing polycistronic pre-mRNAs that require processing into individual mRNAs by spliced leader trans splicing and polyadenylation. While each parasite mRNA is trans-spliced, this particular splicing process is absent in mammalian and insect hosts of kinetoplastids. We recently discovered that the cyclin-dependent kinase (CDK) CRK9 of the kinetoplastid Trypanosoma brucei is essential for trans splicing and parasite viability. Due to the essential roles of CDKs in cell proliferation, CDK inhibition is an established strategy against cancer, suggesting that chemotherapeutic intervention of CRK9 will halt proliferation of kinetoplastid parasites in their hosts. To enable inhibitor studies of CRK9, we have characterized the CRK9 enzyme complex and discovered a new cyclin and a kinetoplastid-specific protein, both of which are essential for the formation of active CRK9. The tripartite nature of the CRK9 complex and sequence insertions that disrupt both kinase and cyclin domains suggest that CRK9 deviates structurally from human CDKs. Finally, by demonstrating that CRK9 ablation prevented trypanosomes from establishing lethal infections in mice, we validated CRK9 as a potential anti-parasitic drug target.
Databáze: OpenAIRE